Effect of Combined Aerobic and Resisted Exercise in Breast Cancer Survivors
NCT ID: NCT00877188
Last Updated: 2012-12-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2009-01-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
exercise
supervised combined aerobic and resistance training for 12 weeks
exercise
supervised combined aerobic and progressive resistance training for 12 weeks
control
waist list control with usual care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
exercise
supervised combined aerobic and progressive resistance training for 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* complete adjuvant therapy \> 2 months, except hormone therapy
* \> 18 years
Exclusion Criteria
* medical or musculoskeletal condition which resistance exercise is contraindicated
* medication which may alter exercise response
18 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jau-Yih Tsauo, PHD
Role: STUDY_CHAIR
Graduate School of Physical Therapy, College of Medicine, Nationall Taiwan University, Taipei, Taiwan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Graduate School of Physical Therapy, College of Medicine, NTU
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NTUH98-M1178
Identifier Type: -
Identifier Source: secondary_id
200808034R
Identifier Type: -
Identifier Source: org_study_id